Currently used and investigational drugs for Cushing´s disease.

about

Cryptococcal meningitis after transnasal transsphenoidal pituitary microsurgery of ACTH-secreting pituitary adenoma: A case report.Management of NFAs: medical treatment.AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.

P2860

Q40138126-481C4892-F2B5-49F7-AB8C-C2CFC5FA8576 Q47726143-ACC86636-FF16-4D13-95ED-25ABE11DEA41 Q50524034-E1E108B3-4A46-45B2-A908-186CF2A764DE

P2860

Currently used and investigational drugs for Cushing´s disease.

Item

http://www.wikidata.org/entity/Q39022297

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Currently used and investigational drugs for Cushing´s disease.

@en

Currently used and investigational drugs for Cushing´s disease.

@nl

type

Item

label

Currently used and investigational drugs for Cushing´s disease.

@en

Currently used and investigational drugs for Cushing´s disease.

@nl

prefLabel

Currently used and investigational drugs for Cushing´s disease.

@en

Currently used and investigational drugs for Cushing´s disease.

@nl

P1476

Currently used and investigational drugs for Cushing´s disease.

@en

P2093

Aizhar G Mumbach

http://www.w3.org/2001/XMLSchema#string

Denis Ciato

http://www.w3.org/2001/XMLSchema#string

Günter K Stalla

http://www.w3.org/2001/XMLSchema#string

Marcelo Paez-Pereda

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic therapy of Cushing's syndrome

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

The Treatment of Cushing's Disease.

Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis

Retinoic acid prevents experimental Cushing syndrome

Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

The use of silymarin in the treatment of liver diseases.

Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

P304

75-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1266338

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Günter Stalla

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27894193

http://www.w3.org/2001/XMLSchema#string

Currently used and investigational drugs for Cushing´s disease.

about

P2860

P2860

Currently used and investigational drugs for Cushing´s disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698